BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ma L, Liu J, Wang W, Yang F, Li P, Cai S, Zhou X, Chen X, Zhuang X, Zhang H, Cao G. Direct-acting antivirals and interferon-based therapy on hepatocellular carcinoma risk in chronic hepatitis-C patients. Future Oncol. 2020;16:675-686. [PMID: 32223423 DOI: 10.2217/fon-2019-0845] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 He Y, Huang M, Tang C, Yue Y, Liu X, Zheng Z, Dong H, Liu D. Dietary daidzein inhibits hepatitis C virus replication by decreasing microRNA-122 levels. Virus Res 2021;298:198404. [PMID: 33775754 DOI: 10.1016/j.virusres.2021.198404] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Servin-Rojas M, Tapia-Sosa R, Páez-Zayas VM, Dithurbide-Hernández M, García-Juárez I. Reply to Alexander Ng. Response to Letter to the Editor. Rev Gastroenterol Mex (Engl Ed) 2022:S2255-534X(21)00144-4. [PMID: 34996737 DOI: 10.1016/j.rgmxen.2021.07.007] [Reference Citation Analysis]
3 Muzica CM, Stanciu C, Huiban L, Singeap AM, Sfarti C, Zenovia S, Cojocariu C, Trifan A. Hepatocellular carcinoma after direct-acting antiviral hepatitis C virus therapy: A debate near the end. World J Gastroenterol 2020; 26(43): 6770-6781 [PMID: 33268960 DOI: 10.3748/wjg.v26.i43.6770] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]